Status:
TERMINATED
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
Lead Sponsor:
Juno Therapeutics, a Subsidiary of Celgene
Conditions:
Non Hodgkin Lymphoma
Multiple Myeloma
Eligibility:
All Genders
Brief Summary
This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be followed for up ...
Eligibility Criteria
Inclusion
- Patients who have received at least one dose of a Juno CAR T-cell product (listed above) in a Juno-sponsored clinical trial
- Patients who have provided informed consent for the long-term follow-up study
Exclusion
- None. All patients who have previously received treatment with a Juno CAR T-cell product are eligible for this long-term follow-up study.
Key Trial Info
Start Date :
February 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2018
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03436771
Start Date
February 19 2018
End Date
July 20 2018
Last Update
May 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope
Duarte, California, United States, 91010
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114